# Clearway Energy, Inc.: financial statements, quarterly

CWEN · NYSE · CIK 1567683 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cwen.md) · [Financials](/companies/cwen/financials.md) · [Filings](/companies/cwen/filings.md) · [Insiders](/companies/cwen/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cwen/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [371](/filings/0001567683-24-000029.md) | [249 d](/filings/0001628280-26-010952.md) | [263](/filings/0001567683-25-000015.md) | [366](/filings/0001567683-25-000025.md) | [486](/filings/0001628280-25-049051.md) | [256 d](/filings/0001628280-26-010952.md) | [298](/filings/0001628280-26-032385.md) | [392](/filings/0001628280-26-053421.md) | [429](/filings/0001628280-25-049051.md) | [310 d](/filings/0001628280-26-010952.md) | [354](/filings/0001628280-26-032385.md) | [481](/filings/0001628280-26-053421.md) |
| Cost of revenue | $m | [134](/filings/0001567683-24-000029.md) | [113 d](/filings/0001628280-26-010952.md) | [126](/filings/0001567683-25-000015.md) | [117](/filings/0001567683-25-000025.md) | [135](/filings/0001628280-25-049051.md) | [123 d](/filings/0001628280-26-010952.md) | [122](/filings/0001628280-26-032385.md) | [131](/filings/0001628280-26-053421.md) | [128](/filings/0001628280-25-049051.md) | [149 d](/filings/0001628280-26-010952.md) | [134](/filings/0001628280-26-032385.md) | [149](/filings/0001628280-26-053421.md) |
| Operating income | $m | [94.0](/filings/0001567683-24-000029.md) | [(22.0) d](/filings/0001628280-26-010952.md) | [(29.0)](/filings/0001567683-25-000015.md) | [84.0](/filings/0001567683-25-000025.md) | [178](/filings/0001628280-25-049051.md) | [(37.0) d](/filings/0001628280-26-010952.md) | [0.0](/filings/0001628280-26-032385.md) | [85.0](/filings/0001628280-26-053421.md) | [112](/filings/0001628280-25-049051.md) | [(37.0) d](/filings/0001628280-26-010952.md) | [20.0](/filings/0001628280-26-032385.md) | [116](/filings/0001628280-26-053421.md) |
| Interest expense | $m | [48.0](/filings/0001567683-24-000029.md) | [135 d](/filings/0001628280-26-010952.md) | [57.0](/filings/0001567683-25-000015.md) | [88.0](/filings/0001567683-25-000025.md) | [139](/filings/0001628280-25-049051.md) | [23.0 d](/filings/0001628280-26-010952.md) | [116](/filings/0001628280-26-032385.md) | [83.0](/filings/0001628280-26-053421.md) | [98.0](/filings/0001628280-25-049051.md) | [90.0 d](/filings/0001628280-26-010952.md) | [101](/filings/0001628280-26-032385.md) | [105](/filings/0001628280-26-053421.md) |
| Income tax | $m | [57.0](/filings/0001567683-24-000029.md) | [(69.0) d](/filings/0001628280-26-010952.md) | [(13.0)](/filings/0001567683-25-000015.md) | [10.0](/filings/0001567683-25-000025.md) | [33.0](/filings/0001628280-25-049051.md) | [0.0 d](/filings/0001628280-26-010952.md) | [0.0](/filings/0001628280-26-032385.md) | [5.0](/filings/0001628280-26-053421.md) | [(31.0)](/filings/0001628280-25-049051.md) | [82.0 d](/filings/0001628280-26-010952.md) | [(2.0)](/filings/0001628280-26-032385.md) | [(3.0)](/filings/0001628280-26-053421.md) |
| Net income | $m | [4.0](/filings/0001567683-24-000029.md) | [37.0 d](/filings/0001628280-26-010952.md) | [(2.0)](/filings/0001567683-25-000015.md) | [51.0](/filings/0001567683-25-000025.md) | [36.0](/filings/0001628280-25-049051.md) | [3.0 d](/filings/0001628280-26-010952.md) | [(3.0)](/filings/0001628280-26-032385.md) | [30.0](/filings/0001628280-26-053421.md) | [232](/filings/0001628280-26-010952.md) | [(90.0) d](/filings/0001628280-26-010952.md) | [(163)](/filings/0001628280-26-032385.md) | [122](/filings/0001628280-26-053421.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported
- Basic EPS: not reported

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.6](/filings/0001567683-23-000035.md) | [0.5](/filings/0001567683-25-000007.md) | [0.5](/filings/0001567683-24-000015.md) | [0.2](/filings/0001567683-24-000022.md) | [0.3](/filings/0001567683-24-000029.md) | [0.3](/filings/0001628280-26-010952.md) | [0.3](/filings/0001567683-25-000015.md) | [0.3](/filings/0001567683-25-000025.md) | [0.3](/filings/0001628280-25-049051.md) | [0.2](/filings/0001628280-26-053421.md) | [0.3](/filings/0001628280-26-032385.md) | [0.3](/filings/0001628280-26-053421.md) |
| Current assets | $bn | [1.7](/filings/0001567683-23-000035.md) | [1.6](/filings/0001567683-25-000007.md) | [1.5](/filings/0001567683-24-000015.md) | [1.0](/filings/0001567683-24-000022.md) | [1.1](/filings/0001567683-24-000029.md) | [1.1](/filings/0001628280-26-010952.md) | [1.0](/filings/0001567683-25-000015.md) | [1.2](/filings/0001567683-25-000025.md) | [1.1](/filings/0001628280-25-049051.md) | [1.2](/filings/0001628280-26-053421.md) | [1.1](/filings/0001628280-26-032385.md) | [1.1](/filings/0001628280-26-053421.md) |
| Total assets | $bn | [13.4](/filings/0001567683-23-000035.md) | [14.7](/filings/0001567683-25-000007.md) | [14.9](/filings/0001567683-24-000015.md) | [14.5](/filings/0001567683-24-000022.md) | [14.2](/filings/0001567683-24-000029.md) | [14.3](/filings/0001628280-26-010952.md) | [14.6](/filings/0001628280-26-032385.md) | [16.0](/filings/0001628280-26-053421.md) | [16.1](/filings/0001628280-25-049051.md) | [16.7](/filings/0001628280-26-053421.md) | [16.9](/filings/0001628280-26-032385.md) | [16.8](/filings/0001628280-26-053421.md) |
| Current liabilities | $bn | [0.8](/filings/0001567683-23-000035.md) | [0.9](/filings/0001567683-25-000007.md) | [0.9](/filings/0001567683-24-000015.md) | [0.7](/filings/0001567683-24-000022.md) | [0.7](/filings/0001567683-24-000029.md) | [0.7](/filings/0001628280-26-010952.md) | [0.7](/filings/0001567683-25-000015.md) | [0.8](/filings/0001567683-25-000025.md) | [0.7](/filings/0001628280-25-049051.md) | [1.0](/filings/0001628280-26-053421.md) | [1.0](/filings/0001628280-26-032385.md) | [0.9](/filings/0001628280-26-053421.md) |
| Total liabilities | $bn | [9.1](/filings/0001567683-23-000035.md) | [9.7](/filings/0001567683-25-000007.md) | [9.8](/filings/0001567683-24-000015.md) | [8.8](/filings/0001567683-24-000022.md) | [8.6](/filings/0001567683-24-000029.md) | [8.8](/filings/0001628280-26-010952.md) | [9.2](/filings/0001567683-25-000015.md) | [10.5](/filings/0001567683-25-000025.md) | [10.3](/filings/0001628280-25-049051.md) | [10.7](/filings/0001628280-26-053421.md) | [11.4](/filings/0001628280-26-032385.md) | [11.2](/filings/0001628280-26-053421.md) |
| Long-term debt | $bn | [7.0](/filings/0001567683-23-000035.md) | [7.5](/filings/0001567683-25-000007.md) | [7.6](/filings/0001567683-24-000015.md) | [6.8](/filings/0001567683-24-000022.md) | [6.7](/filings/0001567683-24-000029.md) | [6.8](/filings/0001628280-26-010952.md) | [7.2](/filings/0001567683-25-000015.md) | [8.3](/filings/0001567683-25-000025.md) | [8.1](/filings/0001628280-25-049051.md) | [7.9](/filings/0001628280-26-053421.md) | [8.5](/filings/0001628280-26-032385.md) | [8.5](/filings/0001628280-26-053421.md) |
| Current portion of debt | $bn | [0.5](/filings/0001567683-23-000035.md) | [0.6](/filings/0001567683-25-000007.md) | [0.6](/filings/0001567683-24-000015.md) | [0.4](/filings/0001567683-24-000022.md) | [0.4](/filings/0001567683-24-000029.md) | [0.4](/filings/0001628280-26-010952.md) | [0.4](/filings/0001567683-25-000015.md) | [0.5](/filings/0001567683-25-000025.md) | [0.3](/filings/0001628280-25-049051.md) | [0.7](/filings/0001628280-26-053421.md) | [0.6](/filings/0001628280-26-032385.md) | [0.6](/filings/0001628280-26-053421.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [4.3](/filings/0001567683-24-000029.md) | [5.0](/filings/0001628280-26-010952.md) | [5.0](/filings/0001628280-25-049051.md) | [5.7](/filings/0001628280-25-049051.md) | [5.6](/filings/0001628280-25-049051.md) | [5.6](/filings/0001628280-26-053421.md) | [5.4](/filings/0001628280-26-053421.md) | [5.5](/filings/0001628280-26-053421.md) | [5.7](/filings/0001628280-26-010952.md) | [5.8](/filings/0001628280-26-053421.md) | [5.5](/filings/0001628280-26-053421.md) | [5.5](/filings/0001628280-26-053421.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [287 d](/filings/0001567683-24-000029.md) | [206 d](/filings/0001628280-26-010952.md) | [81.0](/filings/0001567683-25-000015.md) | [196 d](/filings/0001567683-25-000025.md) | [301 d](/filings/0001628280-25-049051.md) | [192 d](/filings/0001628280-26-010952.md) | [95.0](/filings/0001628280-26-032385.md) | [191 d](/filings/0001628280-26-053421.md) | [225 d](/filings/0001628280-25-049051.md) | [177 d](/filings/0001628280-26-010952.md) | [401](/filings/0001628280-26-032385.md) | [214 d](/filings/0001628280-26-053421.md) |
| Capital expenditure | $m | [34.0 d](/filings/0001567683-24-000029.md) | [69.0 d](/filings/0001628280-26-010952.md) | [98.0](/filings/0001567683-25-000015.md) | [104 d](/filings/0001567683-25-000025.md) | [35.0 d](/filings/0001628280-25-049051.md) | [50.0 d](/filings/0001628280-26-010952.md) | [56.0](/filings/0001628280-26-032385.md) | [76.0 d](/filings/0001628280-26-053421.md) | [81.0 d](/filings/0001628280-25-049051.md) | [106 d](/filings/0001628280-26-010952.md) | [75.0](/filings/0001628280-26-032385.md) | [84.0 d](/filings/0001628280-26-053421.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported

## Shares

| Line item | Unit | Q1 FY2014 (2014-03-31) | Q1 FY2016 (2016-03-31) | Q2 FY2016 (2016-06-30) | Q3 FY2016 (2016-09-30) | Q4 FY2016 (2016-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [30.0](/filings/0001567683-14-000009.md) | [63.0](/filings/0001567683-18-000008.md) | [73.0](/filings/0001567683-18-000008.md) | [73.0](/filings/0001567683-18-000008.md) | [63.0](/filings/0001567683-18-000008.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.